United States · FDA National Drug Code directory
Ropivacaine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70121-1733_aa7176ac-f262-4470-a4de-60e288c05ac3
- Product NDC
- 70121-1733
- Form
- INJECTION
- Composition / generic term
- Ropivacaine Hydrochloride
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230317
- Source listing expiry
- 20261231
Source-listed ingredients
- ROPIVACAINE HYDROCHLORIDE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 12 POUCH in 1 CARTON (70121-1733-3) / 1 BAG in 1 POUCH / 200 mL in 1 BAG · 70121-1733-3
- 24 POUCH in 1 CARTON (70121-1733-9) / 1 BAG in 1 POUCH / 200 mL in 1 BAG · 70121-1733-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →